Asimov to integrate Minaris’ OXGENE technology into its AAV Edge producer cell lines to unlock higher manufacturing titers and improved product quality. Philadelphia, PA and Boston, MA – September 24, 2026 – Minaris, a global cell and gene therapy (CGT) CDMO and multimodal biosafety testing organization, and Asimov, the company building an AI-native synthetic biology … Continued